Duke Vaccine and Trials Unit CRS is a clinical research site located in Durham, North Carolina, United States 27703.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Duke Vaccine and Trials Unit CRS has participated in 1 clinical trials.
Therapeutic areas: Respiratory Syncytial Virus (RSV).
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke Vaccine and Trials Unit CRS has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke Vaccine and Trials Unit CRS has 1 clinical trials on record. Their work covers Respiratory Syncytial Virus (RSV).
Duke Vaccine and Trials Unit CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.